Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
377,961.06 Euro
Request Reference:
ULS São José 51031224
Request Name:
Ciclosporina 100 mg/ml sol oral fr 50 ml, Interferão Beta-1A (REBIF 22 mcg cart) 12 M.U.I./ML sol inj cartu 1.5 ml SC, Interferão Beta-1A(REBIF 44 mcg cart) 24 M.U.I./ML sol inj cartu 1.5 ml SC, Sipon
Phase:
Tendering Phase
State:
Awarded
Description:
Ciclosporina 100 mg/ml sol oral fr 50 ml, Interferão Beta-1A (REBIF 22 mcg cart) 12 M.U.I./ML sol inj cartu 1.5 ml SC, Interferão Beta-1A(REBIF 44 mcg cart) 24 M.U.I./ML sol inj cartu 1.5 ml SC, Siponimod 2 mg comp e Temozolomida 100 mg cáps
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
C574 - CICLOSPORINA (sol oral) [100 MG/ML; FRS]
-
6
(
Months
)
I946 - INTERFERÃO BETA-1A [12 MUI/ML; 1,5 ML; SOL INJ; CARTUCHO]
-
6
(
Months
)
I948 - INTERFERÃO BETA-1A [24 M.U.I./ML; 1,5 ML; CARTUCHO]
-
6
(
Months
)
S1765 - SIPONIMOD [2 MG; CÁP/ COMP]
-
6
(
Months
)
T304 - TEMOZOLOMIDA [100 MG; CÁP/COMP]
-
6
(
Months
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Rua José António Serrano 1150-199 Arroios Lisboa PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
6/24/2024 10:32 AM
(UTC +1 hour)
National official publishing date and time (DR):
9/4/2023 10:00 AM
(UTC +1 hour)
Due datetime for receiving replies:
6/26/2024 4:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
convite 51031224.pdf
convite 51031224.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Lot Title
C574 - CICLOSPORINA (sol oral) [100 MG/ML; FRS]
Base Price
682,72
1.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
C574
CICLOSPORINA (sol oral) [100 MG/ML; FRS]
8,000000
NXTWY.UMT.17649
Buyer Comment:
500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023491/128/0324 | NºAIM:8611400;
TOTAL
(The amounts shown do not include VAT)
2
Lot Title
I946 - INTERFERÃO BETA-1A [12 MUI/ML; 1,5 ML; SOL INJ; CARTUCHO]
Base Price
121 515,00
2.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
I946
INTERFERÃO BETA-1A [12 MUI/ML; 1,5 ML; SOL INJ; CARTUCHO]
1 000,000000
NXTWY.UMT.17649
Buyer Comment:
500650870 | Merck, S.A. | CPA:2023491/119/0007 | NºAIM:5176060;
TOTAL
(The amounts shown do not include VAT)
3
Lot Title
I948 - INTERFERÃO BETA-1A [24 M.U.I./ML; 1,5 ML; CARTUCHO]
Base Price
211 916,32
3.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
I948
INTERFERÃO BETA-1A [24 M.U.I./ML; 1,5 ML; CARTUCHO]
1 336,000000
NXTWY.UMT.17649
Buyer Comment:
500650870 | Merck, S.A. | CPA:2023491/119/0008 | NºAIM:5176078;
TOTAL
(The amounts shown do not include VAT)
4
Lot Title
S1765 - SIPONIMOD [2 MG; CÁP/ COMP]
Base Price
42 888,58
4.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
S1765
SIPONIMOD [2 MG; CÁP/ COMP]
1 334,000000
NXTWY.UMT.17649
Buyer Comment:
500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023491/128/0360 | NºAIM:5790316;
TOTAL
(The amounts shown do not include VAT)
5
Lot Title
T304 - TEMOZOLOMIDA [100 MG; CÁP/COMP]
Base Price
958,44
5.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
T304
TEMOZOLOMIDA [100 MG; CÁP/COMP]
80,000000
NXTWY.UMT.17649
Buyer Comment:
500191360 | Merck Sharp & Dohme, Lda. | CPA:2023491/193/0439 | NºAIM:5177803; 508622263 | Accord Healthcare, Unipessoal, Lda. | CPA:2023491/528/0619 | NºAIM:5656517;
TOTAL
(The amounts shown do not include VAT)
Evaluation
Evaluation
Vision
Avaliação
Definir modelo de avaliação
Sim
Não
Modalidade de avaliação
Selecione…
Monofator
Método de Avaliação
Selecione…
Manual
Divulgar critérios de avaliação
Sim
Não
Critérios da Avaliação
1 - C574 - CICLOSPORINA (sol oral) [100 MG/ML; FRS]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
2 - I946 - INTERFERÃO BETA-1A [12 MUI/ML; 1,5 ML; SOL INJ; CARTUCHO]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
3 - I948 - INTERFERÃO BETA-1A [24 M.U.I./ML; 1,5 ML; CARTUCHO]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
4 - S1765 - SIPONIMOD [2 MG; CÁP/ COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
5 - T304 - TEMOZOLOMIDA [100 MG; CÁP/COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...